Log in | Register

Fully Integrated Batch Terminal

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Fully Integrated Batch Terminal

The new IND780batch stand-alone batch controller combines advanced batching control technology and also adheres to the ISA SP-88 batch standard. It optimizes batch processes with consistent, accurate material transfers to minimize material waste, improve batch quality, and yield increased profits. It is a powerful and flexible stand-alone terminal for single or multi-scale batching applications. It is a flexible controller providing both manual (materials added by hand) batch operation or fully automated (machine controlled) batching control. Manual material formulation leads operators through set formulation recipes and eliminates variables that can cost companies money. Users can take control of manual processes with dependable recipe management and the ability to handle 999 materials. Tolerance checking, material identification via bar-code input, and operator prompting all help to ensure the operator is guided through each batch. Multi-material automatic batching control handles up to 28 automatic materials with recipe-specific control, including conditional control tasks, go-to commands, recipe re-scaling, timing functions, and control of discrete inputs and outputs to allow the controller to interact with other equipment in the process. It features track and trace functionality, multi-language user interface, graphic visualization of batching system status, zone 2/22 class 1 division 2 hazardous area approval,  IP69k environment protection, and it meets most legal metrology standards worldwide.


Mettler-Toledo, Inc., Columbus, OH 43240. www.mt.com or call 614-438-4511

 

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter